Author Interviews, Pain Research / 11.09.2025
FDA Approves Tonmya: First-in-Class, Non-Opioid Analgesic for Fibromyalgia
[caption id="attachment_70643" align="alignleft" width="200"]
Dr. Jain[/caption]
MedicalResearch.com Interview with:
Rakesh Jain, MD, MPH
Clinical Professor at the Department of Psychiatry
Texas Tech University School of Medicine- Permian Basin
Midland, Texas
MedicalResearch.com: Would you briefly explain the condition of fibromyalgia? Whom does it primarily affect and what are the symptoms?
Response: Fibromyalgia is the prototypical example of a type of pain called nociplastic pain, or pain that comes from altered pain processing in the central nervous system. It is mainly characterized by widespread pain, non-restorative sleep, fatigue and cognitive impairment (brain fog). Over 10 million adults in the United States are affected by this disease, most of whom are women.
Dr. Jain[/caption]
MedicalResearch.com Interview with:
Rakesh Jain, MD, MPH
Clinical Professor at the Department of Psychiatry
Texas Tech University School of Medicine- Permian Basin
Midland, Texas
MedicalResearch.com: Would you briefly explain the condition of fibromyalgia? Whom does it primarily affect and what are the symptoms?
Response: Fibromyalgia is the prototypical example of a type of pain called nociplastic pain, or pain that comes from altered pain processing in the central nervous system. It is mainly characterized by widespread pain, non-restorative sleep, fatigue and cognitive impairment (brain fog). Over 10 million adults in the United States are affected by this disease, most of whom are women.
